JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.54% |
| 2 | Financials | 14.6% |
| 3 | Technology | 12.1% |
| 4 | Healthcare | 9.76% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4526
JinkoSolar
JKS
$438M
| $9K | ﹤0.01% |
346
-17,790
| -98% | -$463K |
2017 Q2
1 quarter
|
|
4527
Mastech Digital
MHH
$77.1M
| $9K | ﹤0.01% |
+1,400
| New | +$6.45K |
2017 Q3
0 quarters
|
|
4528
NatWest
NWG
$69.2B
| $9K | ﹤0.01% |
1,154
+173
| +18% | +$1.25K |
2014 Q2
13 quarters
|
|
4529
Oramed Pharmaceuticals
ORMP
$174M
| $9K | ﹤0.01% |
+885
| New | +$7.63K |
2017 Q3
0 quarters
|
|
4530
Primoris Services
PRIM
$3.97B
| $9K | ﹤0.01% |
300
-7,104
| -96% | -$189K |
2015 Q4
7 quarters
|
|
4531
Sify Technologies
SIFY
$851M
| $9K | ﹤0.01% |
1,165
| – | – |
2015 Q4
7 quarters
|
|
4532
Stratasys
SSYS
$624M
| $9K | ﹤0.01% |
416
+165
| +66% | +$3.81K |
2015 Q3
8 quarters
|
|
4533
aTyr Pharma
ATYR
$18M
| $9K | ﹤0.01% |
+129
| New | +$5.98K |
2017 Q3
0 quarters
|
|
|
TCON
4534
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $9K | ﹤0.01% |
+14
| New | +$7.29K |
2017 Q3
0 quarters
|
|
4535
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $9K | ﹤0.01% |
28,852
| – | – |
2016 Q2
5 quarters
|
|
|
XENT
4536
DELISTED
Intersect ENT, Inc
XENT
| $9K | ﹤0.01% |
296
-75,336
| -100% | -$2.23M |
2014 Q3
12 quarters
|
|
|
DNI
4537
DELISTED
Dividend and Income Fund
DNI
| $9K | ﹤0.01% |
+707
| New | +$8.84K |
2017 Q3
0 quarters
|
|
|
STML
4538
DELISTED
Stemline Therapeutics, Inc.
STML
| $9K | ﹤0.01% |
+793
| New | +$7.46K |
2017 Q3
0 quarters
|
|
|
OTIV
4539
DELISTED
OTI On Track Innovations Ltd
OTIV
| $9K | ﹤0.01% |
7,012
| – | – |
2016 Q3
4 quarters
|
|
4540
DELISTED
Viacom Inc. Class A
VIA
| $9K | ﹤0.01% |
244
-1,347
| -85% | -$52.2K |
2015 Q4
7 quarters
|
|
|
NTP
4541
DELISTED
Nam Tai Property Inc.
NTP
| $9K | ﹤0.01% |
850
+352
| +71% | +$3.54K |
2015 Q4
7 quarters
|
|
4542
Ardelyx
ARDX
$844M
| $8K | ﹤0.01% |
+1,449
| New | +$7.63K |
2017 Q3
0 quarters
|
|
4543
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.86B
| $8K | ﹤0.01% |
+300
| New | +$7.38K |
2017 Q3
0 quarters
|
|
4544
Invesco DB Base Metals Fund
DBB
$355M
| $8K | ﹤0.01% |
420
-2,325
| -85% | -$40.5K |
2017 Q1
2 quarters
|
|
4545
Inseego
INSG
$73M
| $8K | ﹤0.01% |
562
-11
| -2% | -$141 |
2016 Q4
3 quarters
|
|
4546
Scorpio Tankers
STNG
$4.15B
| $8K | ﹤0.01% |
236
+32
| +16% | +$1.16K |
2015 Q4
7 quarters
|
|
4547
Teekay Tankers
TNK
$3.37B
| $8K | ﹤0.01% |
595
+82
| +16% | +$1.05K |
2016 Q4
3 quarters
|
|
4548
Vicor
VICR
$10.1B
| $8K | ﹤0.01% |
356
+54
| +18% | +$1.02K |
2016 Q1
6 quarters
|
|
|
SMIT
4549
DELISTED
Schmitt Industries Inc
SMIT
| $8K | ﹤0.01% |
4,000
| – | – |
2017 Q1
2 quarters
|
|
|
IIN
4550
DELISTED
IntriCon Corporation
IIN
| $8K | ﹤0.01% |
+700
| New | +$6.37K |
2017 Q3
0 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 501 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 501 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.